NFE2L2 and triple-negative breast carcinoma: For example, De Blasio and his co-workers demonstrated that Nrf2 upgraded both the proliferation and antioxidant capacity in triple-negative breast cancer (TNBC) cells by downmodulating miR-29b-1-5p expression.